Cancer News and Research

Latest Cancer News and Research

100BMOA releases official statement on prostate cancer

100 Black Men of America, Inc., Chairman Albert E. Dotson, Jr., the Board of Directors and the Executive Committee of 100 Black Men of America, Inc. release an official statement on prostate cancer, in an effort to save lives of countless men who are at the highest risk of developing prostate cancer.

18 Jun 2012

Updated results from two clinical trials of Bruton's ibrutinib for CLL/SLL

Pharmacyclics, Inc announced today at the 17th Congress of European Hematology Association updated results from two clinical trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

18 Jun 2012

Tobacco cessation must be included as part of standard clinical care for cancer patients

While tobacco use can significantly hamper cancer treatment, few cancer researchers are incorporating tobacco assessment into their clinical studies. That's the conclusion a group of investigators led by Graham Warren, MD, PhD, Assistant Professor in the Department of Radiation Medicine at Roswell Park Cancer Institute (RPCI), drew from a recent survey of cancer clinical trials.

16 Jun 2012

Stereotactic ablative radiotherapy benefits stage I non-small cell lung cancer patients

Until recently, many elderly patients with stage I non-small cell lung cancer were left untreated because treatment may not improve their quality of life. However, stereotactic ablative radiotherapy (SABR) has become one of the standards of treatment for these patients. The outpatient treatment given over a two-week period allows frail patients to undergo the treatment.

16 Jun 2012

Study reveals value of graphic warning labels on cigarette packaging

In a first of its kind study in the U.S., researchers at the Perelman School of Medicine at the University of Pennsylvania have shown that the addition of graphic warning labels on cigarette packaging can improve smokers' recall of the warning and health risks associated with smoking. The new findings are published online-first in the American Journal of Preventive Medicine.

16 Jun 2012

Bristol-Myers Squibb, Scripps Research enter five-year collaboration

The Scripps Research Institute today announced it has entered into a five-year collaboration with Bristol-Myers Squibb Company focused on applying novel chemistry to drug discovery and synthesis.

16 Jun 2012

$Combination of low-dose vitamin D and calcium does not reduce fracture risk in women$

Combination of low-dose vitamin D and calcium does not reduce fracture risk in women

Vitamin D and calcium are dietary requirements, but it's unclear how much is best for us. New draft findings by the United States Preventive Services Task Force conclude that for healthy, postmenopausal women, daily supplementation with low levels of vitamin D — up to 400 international units — combined with 1,000 milligrams of calcium, does not reduce fracture risk.

16 Jun 2012

St. Michael's to investigate new treatments for prevention of brain injury complications

St. Michael's Hospital has been awarded up to $700,000 from the Federal Economic Development Agency of Southern Ontario to investigate new treatments to prevent complications following certain brain injuries.

16 Jun 2012

Researchers engineer nanoparticles that show great promise for MM

Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow.

16 Jun 2012

Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).

16 Jun 2012

Surgeon specialty, hospital volume important factors in patient outcomes

In other studies, outcomes of specific surgeries has been shown to improve when performed at high-volume centralized centers. Researchers from the Netherlands Cancer Institute wanted to understand if patients undergoing lung cancer resections would benefit from having their procedures performed in a high-volume specialized center.

16 Jun 2012

Patients with NK/T-cell lymphomas might benefit from treatment with JAK inhibitors

A substantial proportion of NK/T-cell lymphomas harbor Janus Kinase 3 gene mutations. Patients with these lymphomas might benefit from treatment with a Janus Kinase inhibitor according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

16 Jun 2012

New approach to drug design may yield more effective and less toxic cancer medicines

A new approach to drug design, pioneered by a group of researchers at the University of California, San Francisco (UCSF) and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.

16 Jun 2012

HCA, HealthONE expand Colorado Center for Robotic Surgery

People who may be considering surgery for a disease or medical condition now have greater access to the most advanced type of minimally invasive procedures available in Colorado. Cherry Creek Shopping Center visitors will be able to "test drive" the new da Vinci Robots in a one-of-a-kind experience on June 18 in the Center's Grand Court.

16 Jun 2012

Researchers identify three sets of genetic markers linked with CNS PNET

Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.

16 Jun 2012

Chemotherapy improves survival for patients with SCLC and LCNEC

Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were treated with perioperative chemotherapy and surgery had better overall survival outcomes than patients treated with surgery alone.

16 Jun 2012

Roundup: Iowa redesign of mental health services raises concerns; Mich. lawmakers opposed to abortion restrictions are 'silenced'

State leaders hope their mental health redesign will bring better services to (rural areas of Iowa), but many front-line administrators doubt they'll see significant improvements soon. In fact, some worry that services could erode over the next year as money and some financial responsibilities are shifted from the counties to the state. Some long-term improvements are possible, they say, but cash likely will run short in the next few months.

15 Jun 2012

Cancer News and Research

Latest Cancer News and Research

100BMOA releases official statement on prostate cancer

Updated results from two clinical trials of Bruton's ibrutinib for CLL/SLL

Tobacco cessation must be included as part of standard clinical care for cancer patients

Stereotactic ablative radiotherapy benefits stage I non-small cell lung cancer patients

Study reveals value of graphic warning labels on cigarette packaging

Bristol-Myers Squibb, Scripps Research enter five-year collaboration

Combination of low-dose vitamin D and calcium does not reduce fracture risk in women

St. Michael's to investigate new treatments for prevention of brain injury complications

Researchers engineer nanoparticles that show great promise for MM

Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML

Surgeon specialty, hospital volume important factors in patient outcomes

Patients with NK/T-cell lymphomas might benefit from treatment with JAK inhibitors

New approach to drug design may yield more effective and less toxic cancer medicines

HCA, HealthONE expand Colorado Center for Robotic Surgery

Researchers identify three sets of genetic markers linked with CNS PNET

Chemotherapy improves survival for patients with SCLC and LCNEC

Roundup: Iowa redesign of mental health services raises concerns; Mich. lawmakers opposed to abortion restrictions are 'silenced'

Drug shows promise as skin cancer treatment

Study calls for overhaul in health care practices for elderly prisoners

New U-M hESC lines now available for federally-funded research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in